Cargando…
Serotonin Concentrations in Platelets, Plasma, Mitral Valve Leaflet, and Left Ventricular Myocardial Tissue in Dogs with Myxomatous Mitral Valve Disease
HYPOTHESIS/OBJECTIVES: Altered serotonin (5‐hydroxytryptamine, 5HT) signaling is postulated in development and progression of canine myxomatous mitral valve disease (MMVD). Little is known regarding platelet, plasma, valvular, or myocardial 5HT concentration ([5HT]) in affected dogs. We quantified [...
Autores principales: | Cremer, S.E., Singletary, G.E., Olsen, L.H., Wallace, K., Häggström, J., Ljungvall, I., Höglund, K., Reynolds, C.A., Pizzinat, N., Oyama, M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895588/ https://www.ncbi.nlm.nih.gov/pubmed/25146933 http://dx.doi.org/10.1111/jvim.12420 |
Ejemplares similares
-
Holter Monitoring of Small Breed Dogs with Advanced Myxomatous Mitral Valve Disease with and without a History of Syncope
por: Rasmussen, C.E., et al.
Publicado: (2014) -
Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease
por: Borgarelli, M., et al.
Publicado: (2015) -
Biopterin Status in Dogs with Myxomatous Mitral Valve Disease is Associated with Disease Severity and Cardiovascular Risk Factors
por: Reimann, M.J., et al.
Publicado: (2014) -
The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease
por: Höglund, Katja, et al.
Publicado: (2020) -
Diagnostic Value of Selected Echocardiographic Variables to Identify Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease
por: Tidholm, A., et al.
Publicado: (2015)